Israel Englander Ascendis Pharma A/S Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Millennium Management LLC holds 473,449 shares of ASND stock, worth $61.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
473,449
Previous 75,000
531.27%
Holding current value
$61.2 Million
Previous $11.3 Million
469.53%
% of portfolio
0.03%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding ASND
# of Institutions
228Shares Held
56.6MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.31 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$642 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$556 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$543 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$507 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.22B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...